Skip to content

Effects of combined transcutaneous electrical acupoint stimulation and general anesthesia on postoperative cognitive function in geriatric patients undergoing thoracoscopic radical resection for lung cancer

Effects of combined transcutaneous electrical acupoint stimulation and general anesthesia on postoperative cognitive function in geriatric patients undergoing thoracoscopic radical resection for lung cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003560
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction, POCD

Interventions

Sponsors

The Second Affiliated Hospital of Air Force Medical University (Tangdu Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Patients are scheduled for thoracoscopic radical resection for lung cancer which may last more than 2 hours; 2) Patients aged 65–90 years; 3) BMI: 18-30kg/?; 4) American Society of Anesthesiologists status I to III; 5) Primary tumor, never had radiotherapy or chemotherapy before; 6) Conduct pulmonary sequestration with a double-lumen tube; 7) Patients are voluntary to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with communication disorders such as language comprehension disorder, mental disorders, epilepsy, history of Parkinson's disease or myasthenia Gravis and so on; 2) History of opioid, alcohol or other drug abuse and addiction; 3) Patients with TEAS contraindications including partial damaged skin, infection or implantable internal electrophysiologic device; 4) History of unstable angina pectoris or myocardial infarction within 3 months; NYHA >= III; 5) Pre-existing hypertension (systolic pressure >= 180 mmHg and/or diastolic pressure >= 110 mmHg), WHO-ISH III; 6) Patients with pre-existing complications of diabetes such as diabetic ketoacidosis, diabetic hyperosmolar coma, kinds of infections, macroangiopathy, nephrosis, retinopathy, diabetic cardiopathy, diabetic neuropathy, diabetes feet and so on; 7) Patients with hepatic and renal insufficiency (Severe abnormality of hepatic function: Of ALT, CB, AST, ALP and TB, one if is twice more than the normal upper limit; Severe abnormality of renal function: Cr 177umol/L); 8) COPD: GOLD III or IV, Lung fibrosis, Uncontrolled asthma; 9) History of pulmonary operation; 10) Unilateral pulmonary resection or bilateral pulmonary operation; 11) Massive hemorrhage in operation; 12) Taking pulmonary sequestration ways such as difficult airway, tracheotomy, occluder, artificial pneumothorax excluded DLT ; 13) Patients took part in other clinical trials within 3 months; 14) The physician in charge or the researcher considers that patients with other inappropriate circumstances in this study (reasons should be recorded).

Design outcomes

Primary

MeasureTime frame
postoperative cognitive function scores;

Secondary

MeasureTime frame
blood gas analysis;analogue scale scores of pain;intraoperative inflammatory reaction;incidence of postoperative complications;

Countries

China

Contacts

Public ContactChangjun Gao

The Second Affiliated Hospital of Air Force Medical University

gaocj74@163.com+86 13379227869

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026